SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-347793
Filing Date
2012-08-09
Accepted
2012-08-09 16:50:08
Documents
9
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d351633d10q.htm 10-Q 247405
2 EX-31 d351633dex31.htm EX-31 10064
3 EX-32 d351633dex32.htm EX-32 3405
  Complete submission text file 0001193125-12-347793.txt   2422777

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT nabi-20120630.xml EX-101.INS 232116
5 XBRL TAXONOMY EXTENSION SCHEMA nabi-20120630.xsd EX-101.SCH 33084
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nabi-20120630_cal.xml EX-101.CAL 39648
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nabi-20120630_def.xml EX-101.DEF 75102
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE nabi-20120630_lab.xml EX-101.LAB 223044
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nabi-20120630_pre.xml EX-101.PRE 170644
Mailing Address 12270 WILKINS AVENUE ROCKVILLE MD 20852
Business Address 12270 WILKINS AVENUE ROCKVILLE MD 20852 301-770-3099
NABI BIOPHARMACEUTICALS (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35285 | Film No.: 121021027
SIC: 2836 Biological Products, (No Diagnostic Substances)